Bafna Pharmaceuticals Limited
Indian Pharmaceutical Exporter ยท Diabetes & Endocrine Specialist ยท $2.4M Total Trade ยท DGFT Verified
Bafna Pharmaceuticals Limited is an Indian pharmaceutical exporter with a total trade value of $2.4M across 6 products in 6 therapeutic categories. Based on 56 verified export shipments from Indian Customs (DGFT) records, the company actively competes across multiple product segments. Top exports include Sitagliptin ($1.3M), Terbinafine ($500.0K), Chlorpheniramine ($300.0K).
Bafna Pharmaceuticals Limited โ Export Portfolio & Destination Treemap

Who is Bafna Pharmaceuticals Limited? โ Company Overview & Market Position
Bafna Pharmaceuticals Limited, established in 1981, is a prominent Indian pharmaceutical company specializing in the manufacturing and export of finished pharmaceutical formulations. The company is headquartered in Chennai, Tamil Nadu, India, at Bafna Towers, 299, Thambu Chetty Street, Chennai - 600 001. As of March 2026, Bafna Pharmaceuticals is a subsidiary of SRJR Lifesciences LLP, with a market capitalization of approximately โน2.35 billion. The company employs around 406 individuals, reflecting its significant presence in the pharmaceutical sector. Bafna Pharmaceuticals is listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) under the ticker symbols BAFNAPH and 532989, respectively. The company's website, bafnapharma.com, provides comprehensive information about its products, services, and corporate initiatives.